Global Antacids

Antacids Comprehensive Study by Type (H2 Antagonist, Acid Neutralizers, Others), Distribution Chanel (Direct, Indirect), Form (Liquid, Chewable Gummy, Tablet, Power), Flavour (Natural, Artificial) Players and Region - Global Market Outlook to 2026

Antacids Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Antacids?
An antacid mainly neutralizes stomach acidity. It is used to het relieve from heartburn and indigestion. It contains salts of aluminium, calcium, magnesium, or sodium. It is available in different artificial and natural flavours. In some cases, antacids are used in the treatment of diarrhoea. Antacids with natural flavors are more popular than artificial once. Rising prevalence of acidity and heartburn owing to uneven eating habitat is mainly driving the demand for antacids. Further, increasing geriatric population has impacted on the demand in positive manner.

The market study is broken down by Type (H2 Antagonist, Acid Neutralizers and Others) and major geographies with country level break-up.

The market of Antacids is expected to grow with rising demand owing to huge prevalence of acidity across the globe. Market specifically witnessing huge demand hence major companies are focusing on expanding their expanding portfolio with new launch. Though side effects associated with use is creating burden on the market. Major players like GSK, Merck KGaA, in the industry are gaining attention from the market. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

GlaxoSmithKline PLC (United Kingdom), Merck (United States), Bayer AG (Germany), Sun Pharmaceuticals Ltd (United States), Pfizer Inc. (United States), AstraZeneca PLC. (United Kingdom), Reddy's Laboratories Ltd (India), Boehringer Ingelheim International GmbH (Germany), Reckitt Benckiser Group Plc (United States), Gemini Pharmaceuticals (United States), R.S. Hughes Co., Inc. (United States), Chempro Pharma Private Limited. (India) and Procter & Gamble (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Antacids market by Type, Application and Region.

On the basis of geography, the market of Antacids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Chanel, the sub-segment i.e. Direct will boost the Antacids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Liquid will boost the Antacids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Flavour, the sub-segment i.e. Natural will boost the Antacids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In February 2021, GSK Consumer Healthcare has launch of TUMS Naturals. It is a new naturally-powered antacid. Company has added this powdered antacids in its TUMS portfolio. This antacid is free-from artificial flavors and dyes to its wide-range of heartburn relief offerings. Thus, company has expanded its product portfolio with this unique launch.


Market Trend
  • Increasing Inclination of towards the Use of Antacids as Functional Agents to Lowers the Acidic Level Raised due to Consumption of Other Drugs

Market Drivers
  • Growing Prevalence of Acidity owing to Changed lifestyle and Uneven Eating Habitats Driving the Demand for Antacids
  • Increasing Pharmaceutical Industry Expenditure
  • Rising Geriatric population

Opportunities
  • Rising Investments from Small Scale Manufacturers for Production of Antacids Has Created Opportunity
  • Growing Pharmaceutical Production Hub in Emerging Countries like China and India

Restraints
  • Side Effects on Health Associated With Excessive Intake of Antacids May Restrain Its Demand

Challenges
  • Risk of Developing Sensitivities to Certain Foods


Key Target Audience
Antacids Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • H2 Antagonist
  • Acid Neutralizers
  • Others
By Distribution Chanel
  • Direct
  • Indirect

By Form
  • Liquid
  • Chewable Gummy
  • Tablet
  • Power

By Flavour
  • Natural
  • Artificial

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Acidity owing to Changed lifestyle and Uneven Eating Habitats Driving the Demand for Antacids
      • 3.2.2. Increasing Pharmaceutical Industry Expenditure
      • 3.2.3. Rising Geriatric population
    • 3.3. Market Challenges
      • 3.3.1. Risk of Developing Sensitivities to Certain Foods
    • 3.4. Market Trends
      • 3.4.1. Increasing Inclination of towards the Use of Antacids as Functional Agents to Lowers the Acidic Level Raised due to Consumption of Other Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antacids, by Type, Distribution Chanel, Form, Flavour and Region (value and volume ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Antacids (Value)
      • 5.2.1. Global Antacids by: Type (Value)
        • 5.2.1.1. H2 Antagonist
        • 5.2.1.2. Acid Neutralizers
        • 5.2.1.3. Others
      • 5.2.2. Global Antacids by: Distribution Chanel (Value)
        • 5.2.2.1. Direct
        • 5.2.2.2. Indirect
      • 5.2.3. Global Antacids by: Form (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Chewable Gummy
        • 5.2.3.3. Tablet
        • 5.2.3.4. Power
      • 5.2.4. Global Antacids by: Flavour (Value)
        • 5.2.4.1. Natural
        • 5.2.4.2. Artificial
      • 5.2.5. Global Antacids Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Antacids (Volume)
      • 5.3.1. Global Antacids by: Type (Volume)
        • 5.3.1.1. H2 Antagonist
        • 5.3.1.2. Acid Neutralizers
        • 5.3.1.3. Others
      • 5.3.2. Global Antacids by: Distribution Chanel (Volume)
        • 5.3.2.1. Direct
        • 5.3.2.2. Indirect
      • 5.3.3. Global Antacids by: Form (Volume)
        • 5.3.3.1. Liquid
        • 5.3.3.2. Chewable Gummy
        • 5.3.3.3. Tablet
        • 5.3.3.4. Power
      • 5.3.4. Global Antacids by: Flavour (Volume)
        • 5.3.4.1. Natural
        • 5.3.4.2. Artificial
      • 5.3.5. Global Antacids Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
  • 6. Antacids: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline PLC (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sun Pharmaceuticals Ltd (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AstraZeneca PLC. (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Reddy's Laboratories Ltd (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Reckitt Benckiser Group Plc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Gemini Pharmaceuticals (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. R.S. Hughes Co., Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Chempro Pharma Private Limited. (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Procter & Gamble (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Antacids Sale, by Type, Distribution Chanel, Form, Flavour and Region (value and volume ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Antacids (Value)
      • 7.2.1. Global Antacids by: Type (Value)
        • 7.2.1.1. H2 Antagonist
        • 7.2.1.2. Acid Neutralizers
        • 7.2.1.3. Others
      • 7.2.2. Global Antacids by: Distribution Chanel (Value)
        • 7.2.2.1. Direct
        • 7.2.2.2. Indirect
      • 7.2.3. Global Antacids by: Form (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Chewable Gummy
        • 7.2.3.3. Tablet
        • 7.2.3.4. Power
      • 7.2.4. Global Antacids by: Flavour (Value)
        • 7.2.4.1. Natural
        • 7.2.4.2. Artificial
      • 7.2.5. Global Antacids Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Antacids (Volume)
      • 7.3.1. Global Antacids by: Type (Volume)
        • 7.3.1.1. H2 Antagonist
        • 7.3.1.2. Acid Neutralizers
        • 7.3.1.3. Others
      • 7.3.2. Global Antacids by: Distribution Chanel (Volume)
        • 7.3.2.1. Direct
        • 7.3.2.2. Indirect
      • 7.3.3. Global Antacids by: Form (Volume)
        • 7.3.3.1. Liquid
        • 7.3.3.2. Chewable Gummy
        • 7.3.3.3. Tablet
        • 7.3.3.4. Power
      • 7.3.4. Global Antacids by: Flavour (Volume)
        • 7.3.4.1. Natural
        • 7.3.4.2. Artificial
      • 7.3.5. Global Antacids Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antacids: by Type(USD Million)
  • Table 2. Antacids H2 Antagonist , by Region USD Million (2015-2020)
  • Table 3. Antacids Acid Neutralizers , by Region USD Million (2015-2020)
  • Table 4. Antacids Others , by Region USD Million (2015-2020)
  • Table 5. Antacids: by Distribution Chanel(USD Million)
  • Table 6. Antacids Direct , by Region USD Million (2015-2020)
  • Table 7. Antacids Indirect , by Region USD Million (2015-2020)
  • Table 8. Antacids: by Form(USD Million)
  • Table 9. Antacids Liquid , by Region USD Million (2015-2020)
  • Table 10. Antacids Chewable Gummy , by Region USD Million (2015-2020)
  • Table 11. Antacids Tablet , by Region USD Million (2015-2020)
  • Table 12. Antacids Power , by Region USD Million (2015-2020)
  • Table 13. Antacids: by Flavour(USD Million)
  • Table 14. Antacids Natural , by Region USD Million (2015-2020)
  • Table 15. Antacids Artificial , by Region USD Million (2015-2020)
  • Table 16. South America Antacids, by Country USD Million (2015-2020)
  • Table 17. South America Antacids, by Type USD Million (2015-2020)
  • Table 18. South America Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 19. South America Antacids, by Form USD Million (2015-2020)
  • Table 20. South America Antacids, by Flavour USD Million (2015-2020)
  • Table 21. Brazil Antacids, by Type USD Million (2015-2020)
  • Table 22. Brazil Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 23. Brazil Antacids, by Form USD Million (2015-2020)
  • Table 24. Brazil Antacids, by Flavour USD Million (2015-2020)
  • Table 25. Argentina Antacids, by Type USD Million (2015-2020)
  • Table 26. Argentina Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 27. Argentina Antacids, by Form USD Million (2015-2020)
  • Table 28. Argentina Antacids, by Flavour USD Million (2015-2020)
  • Table 29. Rest of South America Antacids, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 31. Rest of South America Antacids, by Form USD Million (2015-2020)
  • Table 32. Rest of South America Antacids, by Flavour USD Million (2015-2020)
  • Table 33. Asia Pacific Antacids, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Antacids, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 36. Asia Pacific Antacids, by Form USD Million (2015-2020)
  • Table 37. Asia Pacific Antacids, by Flavour USD Million (2015-2020)
  • Table 38. China Antacids, by Type USD Million (2015-2020)
  • Table 39. China Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 40. China Antacids, by Form USD Million (2015-2020)
  • Table 41. China Antacids, by Flavour USD Million (2015-2020)
  • Table 42. Japan Antacids, by Type USD Million (2015-2020)
  • Table 43. Japan Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 44. Japan Antacids, by Form USD Million (2015-2020)
  • Table 45. Japan Antacids, by Flavour USD Million (2015-2020)
  • Table 46. India Antacids, by Type USD Million (2015-2020)
  • Table 47. India Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 48. India Antacids, by Form USD Million (2015-2020)
  • Table 49. India Antacids, by Flavour USD Million (2015-2020)
  • Table 50. South Korea Antacids, by Type USD Million (2015-2020)
  • Table 51. South Korea Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 52. South Korea Antacids, by Form USD Million (2015-2020)
  • Table 53. South Korea Antacids, by Flavour USD Million (2015-2020)
  • Table 54. Taiwan Antacids, by Type USD Million (2015-2020)
  • Table 55. Taiwan Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 56. Taiwan Antacids, by Form USD Million (2015-2020)
  • Table 57. Taiwan Antacids, by Flavour USD Million (2015-2020)
  • Table 58. Australia Antacids, by Type USD Million (2015-2020)
  • Table 59. Australia Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 60. Australia Antacids, by Form USD Million (2015-2020)
  • Table 61. Australia Antacids, by Flavour USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Antacids, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Antacids, by Form USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Antacids, by Flavour USD Million (2015-2020)
  • Table 66. Europe Antacids, by Country USD Million (2015-2020)
  • Table 67. Europe Antacids, by Type USD Million (2015-2020)
  • Table 68. Europe Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 69. Europe Antacids, by Form USD Million (2015-2020)
  • Table 70. Europe Antacids, by Flavour USD Million (2015-2020)
  • Table 71. Germany Antacids, by Type USD Million (2015-2020)
  • Table 72. Germany Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 73. Germany Antacids, by Form USD Million (2015-2020)
  • Table 74. Germany Antacids, by Flavour USD Million (2015-2020)
  • Table 75. France Antacids, by Type USD Million (2015-2020)
  • Table 76. France Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 77. France Antacids, by Form USD Million (2015-2020)
  • Table 78. France Antacids, by Flavour USD Million (2015-2020)
  • Table 79. Italy Antacids, by Type USD Million (2015-2020)
  • Table 80. Italy Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 81. Italy Antacids, by Form USD Million (2015-2020)
  • Table 82. Italy Antacids, by Flavour USD Million (2015-2020)
  • Table 83. United Kingdom Antacids, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 85. United Kingdom Antacids, by Form USD Million (2015-2020)
  • Table 86. United Kingdom Antacids, by Flavour USD Million (2015-2020)
  • Table 87. Netherlands Antacids, by Type USD Million (2015-2020)
  • Table 88. Netherlands Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 89. Netherlands Antacids, by Form USD Million (2015-2020)
  • Table 90. Netherlands Antacids, by Flavour USD Million (2015-2020)
  • Table 91. Rest of Europe Antacids, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 93. Rest of Europe Antacids, by Form USD Million (2015-2020)
  • Table 94. Rest of Europe Antacids, by Flavour USD Million (2015-2020)
  • Table 95. MEA Antacids, by Country USD Million (2015-2020)
  • Table 96. MEA Antacids, by Type USD Million (2015-2020)
  • Table 97. MEA Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 98. MEA Antacids, by Form USD Million (2015-2020)
  • Table 99. MEA Antacids, by Flavour USD Million (2015-2020)
  • Table 100. Middle East Antacids, by Type USD Million (2015-2020)
  • Table 101. Middle East Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 102. Middle East Antacids, by Form USD Million (2015-2020)
  • Table 103. Middle East Antacids, by Flavour USD Million (2015-2020)
  • Table 104. Africa Antacids, by Type USD Million (2015-2020)
  • Table 105. Africa Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 106. Africa Antacids, by Form USD Million (2015-2020)
  • Table 107. Africa Antacids, by Flavour USD Million (2015-2020)
  • Table 108. North America Antacids, by Country USD Million (2015-2020)
  • Table 109. North America Antacids, by Type USD Million (2015-2020)
  • Table 110. North America Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 111. North America Antacids, by Form USD Million (2015-2020)
  • Table 112. North America Antacids, by Flavour USD Million (2015-2020)
  • Table 113. United States Antacids, by Type USD Million (2015-2020)
  • Table 114. United States Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 115. United States Antacids, by Form USD Million (2015-2020)
  • Table 116. United States Antacids, by Flavour USD Million (2015-2020)
  • Table 117. Canada Antacids, by Type USD Million (2015-2020)
  • Table 118. Canada Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 119. Canada Antacids, by Form USD Million (2015-2020)
  • Table 120. Canada Antacids, by Flavour USD Million (2015-2020)
  • Table 121. Mexico Antacids, by Type USD Million (2015-2020)
  • Table 122. Mexico Antacids, by Distribution Chanel USD Million (2015-2020)
  • Table 123. Mexico Antacids, by Form USD Million (2015-2020)
  • Table 124. Mexico Antacids, by Flavour USD Million (2015-2020)
  • Table 125. Antacids Sales: by Type(K Tons)
  • Table 126. Antacids Sales H2 Antagonist , by Region K Tons (2015-2020)
  • Table 127. Antacids Sales Acid Neutralizers , by Region K Tons (2015-2020)
  • Table 128. Antacids Sales Others , by Region K Tons (2015-2020)
  • Table 129. Antacids Sales: by Distribution Chanel(K Tons)
  • Table 130. Antacids Sales Direct , by Region K Tons (2015-2020)
  • Table 131. Antacids Sales Indirect , by Region K Tons (2015-2020)
  • Table 132. Antacids Sales: by Form(K Tons)
  • Table 133. Antacids Sales Liquid , by Region K Tons (2015-2020)
  • Table 134. Antacids Sales Chewable Gummy , by Region K Tons (2015-2020)
  • Table 135. Antacids Sales Tablet , by Region K Tons (2015-2020)
  • Table 136. Antacids Sales Power , by Region K Tons (2015-2020)
  • Table 137. Antacids Sales: by Flavour(K Tons)
  • Table 138. Antacids Sales Natural , by Region K Tons (2015-2020)
  • Table 139. Antacids Sales Artificial , by Region K Tons (2015-2020)
  • Table 140. South America Antacids Sales, by Country K Tons (2015-2020)
  • Table 141. South America Antacids Sales, by Type K Tons (2015-2020)
  • Table 142. South America Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 143. South America Antacids Sales, by Form K Tons (2015-2020)
  • Table 144. South America Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 145. Brazil Antacids Sales, by Type K Tons (2015-2020)
  • Table 146. Brazil Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 147. Brazil Antacids Sales, by Form K Tons (2015-2020)
  • Table 148. Brazil Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 149. Argentina Antacids Sales, by Type K Tons (2015-2020)
  • Table 150. Argentina Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 151. Argentina Antacids Sales, by Form K Tons (2015-2020)
  • Table 152. Argentina Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 153. Rest of South America Antacids Sales, by Type K Tons (2015-2020)
  • Table 154. Rest of South America Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 155. Rest of South America Antacids Sales, by Form K Tons (2015-2020)
  • Table 156. Rest of South America Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 157. Asia Pacific Antacids Sales, by Country K Tons (2015-2020)
  • Table 158. Asia Pacific Antacids Sales, by Type K Tons (2015-2020)
  • Table 159. Asia Pacific Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 160. Asia Pacific Antacids Sales, by Form K Tons (2015-2020)
  • Table 161. Asia Pacific Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 162. China Antacids Sales, by Type K Tons (2015-2020)
  • Table 163. China Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 164. China Antacids Sales, by Form K Tons (2015-2020)
  • Table 165. China Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 166. Japan Antacids Sales, by Type K Tons (2015-2020)
  • Table 167. Japan Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 168. Japan Antacids Sales, by Form K Tons (2015-2020)
  • Table 169. Japan Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 170. India Antacids Sales, by Type K Tons (2015-2020)
  • Table 171. India Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 172. India Antacids Sales, by Form K Tons (2015-2020)
  • Table 173. India Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 174. South Korea Antacids Sales, by Type K Tons (2015-2020)
  • Table 175. South Korea Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 176. South Korea Antacids Sales, by Form K Tons (2015-2020)
  • Table 177. South Korea Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 178. Taiwan Antacids Sales, by Type K Tons (2015-2020)
  • Table 179. Taiwan Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 180. Taiwan Antacids Sales, by Form K Tons (2015-2020)
  • Table 181. Taiwan Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 182. Australia Antacids Sales, by Type K Tons (2015-2020)
  • Table 183. Australia Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 184. Australia Antacids Sales, by Form K Tons (2015-2020)
  • Table 185. Australia Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 186. Rest of Asia-Pacific Antacids Sales, by Type K Tons (2015-2020)
  • Table 187. Rest of Asia-Pacific Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 188. Rest of Asia-Pacific Antacids Sales, by Form K Tons (2015-2020)
  • Table 189. Rest of Asia-Pacific Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 190. Europe Antacids Sales, by Country K Tons (2015-2020)
  • Table 191. Europe Antacids Sales, by Type K Tons (2015-2020)
  • Table 192. Europe Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 193. Europe Antacids Sales, by Form K Tons (2015-2020)
  • Table 194. Europe Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 195. Germany Antacids Sales, by Type K Tons (2015-2020)
  • Table 196. Germany Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 197. Germany Antacids Sales, by Form K Tons (2015-2020)
  • Table 198. Germany Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 199. France Antacids Sales, by Type K Tons (2015-2020)
  • Table 200. France Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 201. France Antacids Sales, by Form K Tons (2015-2020)
  • Table 202. France Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 203. Italy Antacids Sales, by Type K Tons (2015-2020)
  • Table 204. Italy Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 205. Italy Antacids Sales, by Form K Tons (2015-2020)
  • Table 206. Italy Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 207. United Kingdom Antacids Sales, by Type K Tons (2015-2020)
  • Table 208. United Kingdom Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 209. United Kingdom Antacids Sales, by Form K Tons (2015-2020)
  • Table 210. United Kingdom Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 211. Netherlands Antacids Sales, by Type K Tons (2015-2020)
  • Table 212. Netherlands Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 213. Netherlands Antacids Sales, by Form K Tons (2015-2020)
  • Table 214. Netherlands Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 215. Rest of Europe Antacids Sales, by Type K Tons (2015-2020)
  • Table 216. Rest of Europe Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 217. Rest of Europe Antacids Sales, by Form K Tons (2015-2020)
  • Table 218. Rest of Europe Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 219. MEA Antacids Sales, by Country K Tons (2015-2020)
  • Table 220. MEA Antacids Sales, by Type K Tons (2015-2020)
  • Table 221. MEA Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 222. MEA Antacids Sales, by Form K Tons (2015-2020)
  • Table 223. MEA Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 224. Middle East Antacids Sales, by Type K Tons (2015-2020)
  • Table 225. Middle East Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 226. Middle East Antacids Sales, by Form K Tons (2015-2020)
  • Table 227. Middle East Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 228. Africa Antacids Sales, by Type K Tons (2015-2020)
  • Table 229. Africa Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 230. Africa Antacids Sales, by Form K Tons (2015-2020)
  • Table 231. Africa Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 232. North America Antacids Sales, by Country K Tons (2015-2020)
  • Table 233. North America Antacids Sales, by Type K Tons (2015-2020)
  • Table 234. North America Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 235. North America Antacids Sales, by Form K Tons (2015-2020)
  • Table 236. North America Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 237. United States Antacids Sales, by Type K Tons (2015-2020)
  • Table 238. United States Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 239. United States Antacids Sales, by Form K Tons (2015-2020)
  • Table 240. United States Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 241. Canada Antacids Sales, by Type K Tons (2015-2020)
  • Table 242. Canada Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 243. Canada Antacids Sales, by Form K Tons (2015-2020)
  • Table 244. Canada Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 245. Mexico Antacids Sales, by Type K Tons (2015-2020)
  • Table 246. Mexico Antacids Sales, by Distribution Chanel K Tons (2015-2020)
  • Table 247. Mexico Antacids Sales, by Form K Tons (2015-2020)
  • Table 248. Mexico Antacids Sales, by Flavour K Tons (2015-2020)
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Antacids: by Type(USD Million)
  • Table 263. Antacids H2 Antagonist , by Region USD Million (2021-2026)
  • Table 264. Antacids Acid Neutralizers , by Region USD Million (2021-2026)
  • Table 265. Antacids Others , by Region USD Million (2021-2026)
  • Table 266. Antacids: by Distribution Chanel(USD Million)
  • Table 267. Antacids Direct , by Region USD Million (2021-2026)
  • Table 268. Antacids Indirect , by Region USD Million (2021-2026)
  • Table 269. Antacids: by Form(USD Million)
  • Table 270. Antacids Liquid , by Region USD Million (2021-2026)
  • Table 271. Antacids Chewable Gummy , by Region USD Million (2021-2026)
  • Table 272. Antacids Tablet , by Region USD Million (2021-2026)
  • Table 273. Antacids Power , by Region USD Million (2021-2026)
  • Table 274. Antacids: by Flavour(USD Million)
  • Table 275. Antacids Natural , by Region USD Million (2021-2026)
  • Table 276. Antacids Artificial , by Region USD Million (2021-2026)
  • Table 277. South America Antacids, by Country USD Million (2021-2026)
  • Table 278. South America Antacids, by Type USD Million (2021-2026)
  • Table 279. South America Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 280. South America Antacids, by Form USD Million (2021-2026)
  • Table 281. South America Antacids, by Flavour USD Million (2021-2026)
  • Table 282. Brazil Antacids, by Type USD Million (2021-2026)
  • Table 283. Brazil Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 284. Brazil Antacids, by Form USD Million (2021-2026)
  • Table 285. Brazil Antacids, by Flavour USD Million (2021-2026)
  • Table 286. Argentina Antacids, by Type USD Million (2021-2026)
  • Table 287. Argentina Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 288. Argentina Antacids, by Form USD Million (2021-2026)
  • Table 289. Argentina Antacids, by Flavour USD Million (2021-2026)
  • Table 290. Rest of South America Antacids, by Type USD Million (2021-2026)
  • Table 291. Rest of South America Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 292. Rest of South America Antacids, by Form USD Million (2021-2026)
  • Table 293. Rest of South America Antacids, by Flavour USD Million (2021-2026)
  • Table 294. Asia Pacific Antacids, by Country USD Million (2021-2026)
  • Table 295. Asia Pacific Antacids, by Type USD Million (2021-2026)
  • Table 296. Asia Pacific Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 297. Asia Pacific Antacids, by Form USD Million (2021-2026)
  • Table 298. Asia Pacific Antacids, by Flavour USD Million (2021-2026)
  • Table 299. China Antacids, by Type USD Million (2021-2026)
  • Table 300. China Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 301. China Antacids, by Form USD Million (2021-2026)
  • Table 302. China Antacids, by Flavour USD Million (2021-2026)
  • Table 303. Japan Antacids, by Type USD Million (2021-2026)
  • Table 304. Japan Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 305. Japan Antacids, by Form USD Million (2021-2026)
  • Table 306. Japan Antacids, by Flavour USD Million (2021-2026)
  • Table 307. India Antacids, by Type USD Million (2021-2026)
  • Table 308. India Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 309. India Antacids, by Form USD Million (2021-2026)
  • Table 310. India Antacids, by Flavour USD Million (2021-2026)
  • Table 311. South Korea Antacids, by Type USD Million (2021-2026)
  • Table 312. South Korea Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 313. South Korea Antacids, by Form USD Million (2021-2026)
  • Table 314. South Korea Antacids, by Flavour USD Million (2021-2026)
  • Table 315. Taiwan Antacids, by Type USD Million (2021-2026)
  • Table 316. Taiwan Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 317. Taiwan Antacids, by Form USD Million (2021-2026)
  • Table 318. Taiwan Antacids, by Flavour USD Million (2021-2026)
  • Table 319. Australia Antacids, by Type USD Million (2021-2026)
  • Table 320. Australia Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 321. Australia Antacids, by Form USD Million (2021-2026)
  • Table 322. Australia Antacids, by Flavour USD Million (2021-2026)
  • Table 323. Rest of Asia-Pacific Antacids, by Type USD Million (2021-2026)
  • Table 324. Rest of Asia-Pacific Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 325. Rest of Asia-Pacific Antacids, by Form USD Million (2021-2026)
  • Table 326. Rest of Asia-Pacific Antacids, by Flavour USD Million (2021-2026)
  • Table 327. Europe Antacids, by Country USD Million (2021-2026)
  • Table 328. Europe Antacids, by Type USD Million (2021-2026)
  • Table 329. Europe Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 330. Europe Antacids, by Form USD Million (2021-2026)
  • Table 331. Europe Antacids, by Flavour USD Million (2021-2026)
  • Table 332. Germany Antacids, by Type USD Million (2021-2026)
  • Table 333. Germany Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 334. Germany Antacids, by Form USD Million (2021-2026)
  • Table 335. Germany Antacids, by Flavour USD Million (2021-2026)
  • Table 336. France Antacids, by Type USD Million (2021-2026)
  • Table 337. France Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 338. France Antacids, by Form USD Million (2021-2026)
  • Table 339. France Antacids, by Flavour USD Million (2021-2026)
  • Table 340. Italy Antacids, by Type USD Million (2021-2026)
  • Table 341. Italy Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 342. Italy Antacids, by Form USD Million (2021-2026)
  • Table 343. Italy Antacids, by Flavour USD Million (2021-2026)
  • Table 344. United Kingdom Antacids, by Type USD Million (2021-2026)
  • Table 345. United Kingdom Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 346. United Kingdom Antacids, by Form USD Million (2021-2026)
  • Table 347. United Kingdom Antacids, by Flavour USD Million (2021-2026)
  • Table 348. Netherlands Antacids, by Type USD Million (2021-2026)
  • Table 349. Netherlands Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 350. Netherlands Antacids, by Form USD Million (2021-2026)
  • Table 351. Netherlands Antacids, by Flavour USD Million (2021-2026)
  • Table 352. Rest of Europe Antacids, by Type USD Million (2021-2026)
  • Table 353. Rest of Europe Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 354. Rest of Europe Antacids, by Form USD Million (2021-2026)
  • Table 355. Rest of Europe Antacids, by Flavour USD Million (2021-2026)
  • Table 356. MEA Antacids, by Country USD Million (2021-2026)
  • Table 357. MEA Antacids, by Type USD Million (2021-2026)
  • Table 358. MEA Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 359. MEA Antacids, by Form USD Million (2021-2026)
  • Table 360. MEA Antacids, by Flavour USD Million (2021-2026)
  • Table 361. Middle East Antacids, by Type USD Million (2021-2026)
  • Table 362. Middle East Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 363. Middle East Antacids, by Form USD Million (2021-2026)
  • Table 364. Middle East Antacids, by Flavour USD Million (2021-2026)
  • Table 365. Africa Antacids, by Type USD Million (2021-2026)
  • Table 366. Africa Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 367. Africa Antacids, by Form USD Million (2021-2026)
  • Table 368. Africa Antacids, by Flavour USD Million (2021-2026)
  • Table 369. North America Antacids, by Country USD Million (2021-2026)
  • Table 370. North America Antacids, by Type USD Million (2021-2026)
  • Table 371. North America Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 372. North America Antacids, by Form USD Million (2021-2026)
  • Table 373. North America Antacids, by Flavour USD Million (2021-2026)
  • Table 374. United States Antacids, by Type USD Million (2021-2026)
  • Table 375. United States Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 376. United States Antacids, by Form USD Million (2021-2026)
  • Table 377. United States Antacids, by Flavour USD Million (2021-2026)
  • Table 378. Canada Antacids, by Type USD Million (2021-2026)
  • Table 379. Canada Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 380. Canada Antacids, by Form USD Million (2021-2026)
  • Table 381. Canada Antacids, by Flavour USD Million (2021-2026)
  • Table 382. Mexico Antacids, by Type USD Million (2021-2026)
  • Table 383. Mexico Antacids, by Distribution Chanel USD Million (2021-2026)
  • Table 384. Mexico Antacids, by Form USD Million (2021-2026)
  • Table 385. Mexico Antacids, by Flavour USD Million (2021-2026)
  • Table 386. Antacids Sales: by Type(K Tons)
  • Table 387. Antacids Sales H2 Antagonist , by Region K Tons (2021-2026)
  • Table 388. Antacids Sales Acid Neutralizers , by Region K Tons (2021-2026)
  • Table 389. Antacids Sales Others , by Region K Tons (2021-2026)
  • Table 390. Antacids Sales: by Distribution Chanel(K Tons)
  • Table 391. Antacids Sales Direct , by Region K Tons (2021-2026)
  • Table 392. Antacids Sales Indirect , by Region K Tons (2021-2026)
  • Table 393. Antacids Sales: by Form(K Tons)
  • Table 394. Antacids Sales Liquid , by Region K Tons (2021-2026)
  • Table 395. Antacids Sales Chewable Gummy , by Region K Tons (2021-2026)
  • Table 396. Antacids Sales Tablet , by Region K Tons (2021-2026)
  • Table 397. Antacids Sales Power , by Region K Tons (2021-2026)
  • Table 398. Antacids Sales: by Flavour(K Tons)
  • Table 399. Antacids Sales Natural , by Region K Tons (2021-2026)
  • Table 400. Antacids Sales Artificial , by Region K Tons (2021-2026)
  • Table 401. South America Antacids Sales, by Country K Tons (2021-2026)
  • Table 402. South America Antacids Sales, by Type K Tons (2021-2026)
  • Table 403. South America Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 404. South America Antacids Sales, by Form K Tons (2021-2026)
  • Table 405. South America Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 406. Brazil Antacids Sales, by Type K Tons (2021-2026)
  • Table 407. Brazil Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 408. Brazil Antacids Sales, by Form K Tons (2021-2026)
  • Table 409. Brazil Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 410. Argentina Antacids Sales, by Type K Tons (2021-2026)
  • Table 411. Argentina Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 412. Argentina Antacids Sales, by Form K Tons (2021-2026)
  • Table 413. Argentina Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 414. Rest of South America Antacids Sales, by Type K Tons (2021-2026)
  • Table 415. Rest of South America Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 416. Rest of South America Antacids Sales, by Form K Tons (2021-2026)
  • Table 417. Rest of South America Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 418. Asia Pacific Antacids Sales, by Country K Tons (2021-2026)
  • Table 419. Asia Pacific Antacids Sales, by Type K Tons (2021-2026)
  • Table 420. Asia Pacific Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 421. Asia Pacific Antacids Sales, by Form K Tons (2021-2026)
  • Table 422. Asia Pacific Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 423. China Antacids Sales, by Type K Tons (2021-2026)
  • Table 424. China Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 425. China Antacids Sales, by Form K Tons (2021-2026)
  • Table 426. China Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 427. Japan Antacids Sales, by Type K Tons (2021-2026)
  • Table 428. Japan Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 429. Japan Antacids Sales, by Form K Tons (2021-2026)
  • Table 430. Japan Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 431. India Antacids Sales, by Type K Tons (2021-2026)
  • Table 432. India Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 433. India Antacids Sales, by Form K Tons (2021-2026)
  • Table 434. India Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 435. South Korea Antacids Sales, by Type K Tons (2021-2026)
  • Table 436. South Korea Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 437. South Korea Antacids Sales, by Form K Tons (2021-2026)
  • Table 438. South Korea Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 439. Taiwan Antacids Sales, by Type K Tons (2021-2026)
  • Table 440. Taiwan Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 441. Taiwan Antacids Sales, by Form K Tons (2021-2026)
  • Table 442. Taiwan Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 443. Australia Antacids Sales, by Type K Tons (2021-2026)
  • Table 444. Australia Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 445. Australia Antacids Sales, by Form K Tons (2021-2026)
  • Table 446. Australia Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 447. Rest of Asia-Pacific Antacids Sales, by Type K Tons (2021-2026)
  • Table 448. Rest of Asia-Pacific Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 449. Rest of Asia-Pacific Antacids Sales, by Form K Tons (2021-2026)
  • Table 450. Rest of Asia-Pacific Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 451. Europe Antacids Sales, by Country K Tons (2021-2026)
  • Table 452. Europe Antacids Sales, by Type K Tons (2021-2026)
  • Table 453. Europe Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 454. Europe Antacids Sales, by Form K Tons (2021-2026)
  • Table 455. Europe Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 456. Germany Antacids Sales, by Type K Tons (2021-2026)
  • Table 457. Germany Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 458. Germany Antacids Sales, by Form K Tons (2021-2026)
  • Table 459. Germany Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 460. France Antacids Sales, by Type K Tons (2021-2026)
  • Table 461. France Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 462. France Antacids Sales, by Form K Tons (2021-2026)
  • Table 463. France Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 464. Italy Antacids Sales, by Type K Tons (2021-2026)
  • Table 465. Italy Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 466. Italy Antacids Sales, by Form K Tons (2021-2026)
  • Table 467. Italy Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 468. United Kingdom Antacids Sales, by Type K Tons (2021-2026)
  • Table 469. United Kingdom Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 470. United Kingdom Antacids Sales, by Form K Tons (2021-2026)
  • Table 471. United Kingdom Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 472. Netherlands Antacids Sales, by Type K Tons (2021-2026)
  • Table 473. Netherlands Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 474. Netherlands Antacids Sales, by Form K Tons (2021-2026)
  • Table 475. Netherlands Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 476. Rest of Europe Antacids Sales, by Type K Tons (2021-2026)
  • Table 477. Rest of Europe Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 478. Rest of Europe Antacids Sales, by Form K Tons (2021-2026)
  • Table 479. Rest of Europe Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 480. MEA Antacids Sales, by Country K Tons (2021-2026)
  • Table 481. MEA Antacids Sales, by Type K Tons (2021-2026)
  • Table 482. MEA Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 483. MEA Antacids Sales, by Form K Tons (2021-2026)
  • Table 484. MEA Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 485. Middle East Antacids Sales, by Type K Tons (2021-2026)
  • Table 486. Middle East Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 487. Middle East Antacids Sales, by Form K Tons (2021-2026)
  • Table 488. Middle East Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 489. Africa Antacids Sales, by Type K Tons (2021-2026)
  • Table 490. Africa Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 491. Africa Antacids Sales, by Form K Tons (2021-2026)
  • Table 492. Africa Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 493. North America Antacids Sales, by Country K Tons (2021-2026)
  • Table 494. North America Antacids Sales, by Type K Tons (2021-2026)
  • Table 495. North America Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 496. North America Antacids Sales, by Form K Tons (2021-2026)
  • Table 497. North America Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 498. United States Antacids Sales, by Type K Tons (2021-2026)
  • Table 499. United States Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 500. United States Antacids Sales, by Form K Tons (2021-2026)
  • Table 501. United States Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 502. Canada Antacids Sales, by Type K Tons (2021-2026)
  • Table 503. Canada Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 504. Canada Antacids Sales, by Form K Tons (2021-2026)
  • Table 505. Canada Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 506. Mexico Antacids Sales, by Type K Tons (2021-2026)
  • Table 507. Mexico Antacids Sales, by Distribution Chanel K Tons (2021-2026)
  • Table 508. Mexico Antacids Sales, by Form K Tons (2021-2026)
  • Table 509. Mexico Antacids Sales, by Flavour K Tons (2021-2026)
  • Table 510. Research Programs/Design for This Report
  • Table 511. Key Data Information from Secondary Sources
  • Table 512. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antacids: by Type USD Million (2015-2020)
  • Figure 5. Global Antacids: by Distribution Chanel USD Million (2015-2020)
  • Figure 6. Global Antacids: by Form USD Million (2015-2020)
  • Figure 7. Global Antacids: by Flavour USD Million (2015-2020)
  • Figure 8. South America Antacids Share (%), by Country
  • Figure 9. Asia Pacific Antacids Share (%), by Country
  • Figure 10. Europe Antacids Share (%), by Country
  • Figure 11. MEA Antacids Share (%), by Country
  • Figure 12. North America Antacids Share (%), by Country
  • Figure 13. Global Antacids: by Type K Tons (2015-2020)
  • Figure 14. Global Antacids: by Distribution Chanel K Tons (2015-2020)
  • Figure 15. Global Antacids: by Form K Tons (2015-2020)
  • Figure 16. Global Antacids: by Flavour K Tons (2015-2020)
  • Figure 17. South America Antacids Share (%), by Country
  • Figure 18. Asia Pacific Antacids Share (%), by Country
  • Figure 19. Europe Antacids Share (%), by Country
  • Figure 20. MEA Antacids Share (%), by Country
  • Figure 21. North America Antacids Share (%), by Country
  • Figure 22. Global Antacids share by Players 2020 (%)
  • Figure 23. Global Antacids share by Players (Top 3) 2020(%)
  • Figure 24. Global Antacids share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. GlaxoSmithKline PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. GlaxoSmithKline PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 29. Merck (United States) Revenue: by Geography 2020
  • Figure 30. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 32. Sun Pharmaceuticals Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 33. Sun Pharmaceuticals Ltd (United States) Revenue: by Geography 2020
  • Figure 34. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 36. AstraZeneca PLC. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. AstraZeneca PLC. (United Kingdom) Revenue: by Geography 2020
  • Figure 38. Reddy's Laboratories Ltd (India) Revenue, Net Income and Gross profit
  • Figure 39. Reddy's Laboratories Ltd (India) Revenue: by Geography 2020
  • Figure 40. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 41. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2020
  • Figure 42. Reckitt Benckiser Group Plc (United States) Revenue, Net Income and Gross profit
  • Figure 43. Reckitt Benckiser Group Plc (United States) Revenue: by Geography 2020
  • Figure 44. Gemini Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 45. Gemini Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 46. R.S. Hughes Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. R.S. Hughes Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 48. Chempro Pharma Private Limited. (India) Revenue, Net Income and Gross profit
  • Figure 49. Chempro Pharma Private Limited. (India) Revenue: by Geography 2020
  • Figure 50. Procter & Gamble (United States) Revenue, Net Income and Gross profit
  • Figure 51. Procter & Gamble (United States) Revenue: by Geography 2020
  • Figure 52. Global Antacids: by Type USD Million (2021-2026)
  • Figure 53. Global Antacids: by Distribution Chanel USD Million (2021-2026)
  • Figure 54. Global Antacids: by Form USD Million (2021-2026)
  • Figure 55. Global Antacids: by Flavour USD Million (2021-2026)
  • Figure 56. South America Antacids Share (%), by Country
  • Figure 57. Asia Pacific Antacids Share (%), by Country
  • Figure 58. Europe Antacids Share (%), by Country
  • Figure 59. MEA Antacids Share (%), by Country
  • Figure 60. North America Antacids Share (%), by Country
  • Figure 61. Global Antacids: by Type K Tons (2021-2026)
  • Figure 62. Global Antacids: by Distribution Chanel K Tons (2021-2026)
  • Figure 63. Global Antacids: by Form K Tons (2021-2026)
  • Figure 64. Global Antacids: by Flavour K Tons (2021-2026)
  • Figure 65. South America Antacids Share (%), by Country
  • Figure 66. Asia Pacific Antacids Share (%), by Country
  • Figure 67. Europe Antacids Share (%), by Country
  • Figure 68. MEA Antacids Share (%), by Country
  • Figure 69. North America Antacids Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline PLC (United Kingdom)
  • Merck (United States)
  • Bayer AG (Germany)
  • Sun Pharmaceuticals Ltd (United States)
  • Pfizer Inc. (United States)
  • AstraZeneca PLC. (United Kingdom)
  • Reddy's Laboratories Ltd (India)
  • Boehringer Ingelheim International GmbH (Germany)
  • Reckitt Benckiser Group Plc (United States)
  • Gemini Pharmaceuticals (United States)
  • R.S. Hughes Co., Inc. (United States)
  • Chempro Pharma Private Limited. (India)
  • Procter & Gamble (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 218 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antacids Quantitative research analysis
Global Antacids Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as GlaxoSmithKline PLC (United Kingdom), Merck (United States), Bayer AG (Germany), Sun Pharmaceuticals Ltd (United States), Pfizer Inc. (United States), AstraZeneca PLC. (United Kingdom), Reddy's Laboratories Ltd (India), Boehringer Ingelheim International GmbH (Germany), Reckitt Benckiser Group Plc (United States), Gemini Pharmaceuticals (United States), R.S. Hughes Co., Inc. (United States), Chempro Pharma Private Limited. (India) and Procter & Gamble (United States) etc.
Analysts at AMA estimates Antacids Market to reach USDXXX by 2026.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Antacids Report?

Have a Query? Click Here

Other Related Reports

Oncology Biosimilars Comprehensive Study by Type (G-CSF, Hematopoietic Agents, Monoclonal Antibodies), Application (Cancer Treatment Drugs, Supportive Care Drugs), Drug type (Monoclonal antibody (mAb...
$ 3750
Hepatitis C Drugs Comprehensive Study by Type (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), Application (Hospitals, Clinics), Disease (Acute Hepatitis C, Chronic Hepatitis C...
$ 3450
Human Vaccines Comprehensive Study by Type (Live-Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, Toxoid Vaccines), Distribution Channel (Hospi...
$ 3450
Thin Film Drug Comprehensive Study by Type (Transdermal Film, Oral Thin Film), Application (Hospitals, Clinics, Others), Indication Type (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting...
$ 3750
Infusion Pharmacy Management Comprehensive Study by Type (Antibiotics, Antimicrobial, Pain Management, Enteral Nutrition, Others), Application (Hospital & Clinic, Ambulatory Surgical Centers, Home Ca...
$ 3350
Active Pharma Ingredient Comprehensive Study by Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Application (Oncology, Cardiovascular Disease, Diabetes...
$ 3750